Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.

Front Immunol · 2023 · PMC10361653 · PMID 37483623

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

However, due to the smaller number of patients, some comparisons failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.